Aegerion Pharmaceuticals to Announce Second Quarter 2014 Financial Results on Tuesday, July 29
22. Juli 2014 16:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., July 22, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
09. Juli 2014 08:30 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., July 9, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
06. Juni 2014 08:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., June 6, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
Aegerion Pharmaceuticals Announces Presentation at the Jefferies 2014 Global Healthcare Conference
28. Mai 2014 08:30 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 28, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
07. Mai 2014 16:05 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 7, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
Aegerion Pharmaceuticals Announces First-Quarter 2014 Financial Results
06. Mai 2014 16:15 ET
|
Aegerion Pharmaceuticals, Inc.
- Company achieves growth in U.S. business of 24% over prior quarter
- Cash flow positive operations anticipated in the second half of...
Aegerion Pharmaceuticals Announces Webcast of Presentations at Upcoming Investor Conferences
30. April 2014 16:10 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...
Aegerion Pharmaceuticals to Announce First Quarter 2014 Financial Results on Tuesday, May 6
30. April 2014 08:30 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...
Aegerion Pharmaceuticals Initiates Phase 3 Clinical Trial in Japan to Evaluate Lomitapide for Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
09. April 2014 08:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 9, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of novel therapies for...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
07. April 2014 16:05 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 7, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...